Pyros Pharmaceuticals Email Format
Pharmaceutical ManufacturingNew Jersey, United States2-10 Employees
Pyros Pharmaceuticals is a specialty pharmaceutical company focused on developing medicines for rare pediatric diseases and underserved patient populations. It pursues a broad range of therapeutic areas that involve technically challenging drug delivery mechanisms or niche applications. The company is based in Parsippany, New Jersey, at 2001 Us-46 Suite 310. It maintains a small workforce of 2 to 10 employees. Recent developments include a partnership with AnovoRx Holdings LLC as the exclusive specialty pharmacy for VIGAFYDE and, in October 2024, Bora Pharmaceuticals Co., Ltd. announced that its board approved the acquisition of Pyros Pharmaceuticals; the company reports revenue in the range of 1 million to 10 million and has funding of about 450 thousand.